Back to Search
PATRICIA RASKIN, PH.D.
PH.D.
Psychologist
NPI: 1992828230Individual
Specialties, Licenses & Credentials
PsychologistPrimary
Psychologist
Code: 103T00000X
006169(NY)
Research & Publications (20)
Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?
PMID 19592630·Diabetes Care·2009
2-rct
Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).
PMID 17941873·Diabetes Obes Metab·2009
4-observational
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).
PMID 19289857·Diabetes Care·2009
2-rct
Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control.
PMID 19531054·Diabetes Obes Metab·2009
4-observational
Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review.
PMID 19436644·Vasc Health Risk Manag·2009
6-review
Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes.
PMID 19565569·Diabetes Metab Res Rev·2009
4-observational
Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
PMID 19515182·Diabetes Obes Metab·2009
4-observational
Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet.
PMID 19476470·Diabetes Obes Metab·2009
4-observational
Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
PMID 18299505·Circulation·2008
8-other
Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy.
PMID 18492945·Diabetes Care·2008
8-other
Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
PMID 18494804·Diabetes Obes Metab·2008
6-review
Does serum 1,5-anhydroglucitol establish a relationship between improvements in HbA1c and postprandial glucose excursions? Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargine.
PMID 18290862·Diabet Med·2008
4-observational
Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism.
PMID 18580168·Anesthesiology·2008
8-other
Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
PMID 19040589·J Cardiometab Syndr·2008
4-observational
Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study.
PMID 17698735·Circulation·2007
4-observational
Effect of pioglitazone therapy on myocardial and hepatic steatosis in insulin-treated patients with type 2 diabetes.
PMID 17850734·J Investig Med·2007
2-rct
Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
PMID 17978591·J Clin Hypertens (Greenwich)·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 115 W 73RD ST, SUITE 1D
NEW YORK, NY 10023 - Phone
- (212) 769-2487
Quick Facts
- NPI
- 1992828230
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile